Detalhe da pesquisa
1.
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.
Parasitol Res
; 122(12): 2917-2931, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768367
2.
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
Biology (Basel)
; 12(6)2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37372136
3.
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice.
Acta Trop
; 246: 106986, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453579